UBS Group’s Vivos Therapeutics VVOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13K Sell
11,046
-1,631
-13% -$2.61K ﹤0.01% 8230
2025
Q4
$25.7K Buy
12,677
+12,575
+12,328% +$31.1K ﹤0.01% 7615
2025
Q3
$316 Sell
102
-142,699
-100% -$647K ﹤0.01% 9738
2025
Q2
$451K Buy
142,801
+140,922
+7,500% +$356K ﹤0.01% 6096
2025
Q1
$5.36K Buy
1,879
+1,490
+383% +$5.85K ﹤0.01% 9007
2024
Q4
$1.67K Buy
389
+311
+399% +$1.04K ﹤0.01% 9185
2024
Q3
$204 Buy
+78
New +$204 ﹤0.01% 9073
2023
Q4
Sell
-370
Closed -$1.78K 9936
2023
Q3
$1.78K Buy
+370
New +$2.79K ﹤0.01% 7834
2023
Q1
Sell
-752
Closed -$7.53K 10449
2022
Q4
$7.53K Buy
752
+365
+94% +$5.34K ﹤0.01% 8888
2022
Q3
$6K Buy
387
+298
+335% +$9.08K ﹤0.01% 9072
2022
Q2
$3K Buy
+89
New +$3.7K ﹤0.01% 9377
2022
Q1
Sell
-683
Closed -$38K 10963
2021
Q4
$38K Buy
683
+567
+489% +$45.6K ﹤0.01% 7174
2021
Q3
$12K Buy
116
+22
+23% +$2.31K ﹤0.01% 7792
2021
Q2
$12K Buy
94
+9
+11% +$1.47K ﹤0.01% 7905
2021
Q1
$14K Buy
+85
New +$15.2K ﹤0.01% 7683

Other funds holding VVOS